178 related articles for article (PubMed ID: 2318965)
1. Regulation of megakaryocyte phenotype in human erythroleukemia cells.
Long MW; Heffner CH; Williams JL; Peters C; Prochownik EV
J Clin Invest; 1990 Apr; 85(4):1072-84. PubMed ID: 2318965
[TBL] [Abstract][Full Text] [Related]
2. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells.
Hong Y; Martin JF; Vainchenker W; Erusalimsky JD
Blood; 1996 Jan; 87(1):123-31. PubMed ID: 8547633
[TBL] [Abstract][Full Text] [Related]
4. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells.
Beneytout JL; Nappez C; Leboutet MJ; Malinvaud G
Biochem Biophys Res Commun; 1995 Feb; 207(1):398-404. PubMed ID: 7857294
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of GATA-1 expression during phorbol myristate acetate-induced megakaryocytic differentiation of human erythroleukemia cells.
Dai W; Murphy MJ
Blood; 1993 Mar; 81(5):1214-21. PubMed ID: 8443382
[TBL] [Abstract][Full Text] [Related]
6. The Evi1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity.
Kilbey A; Alzuherri H; McColl J; Calés C; Frampton J; Bartholomew C
Br J Haematol; 2005 Sep; 130(6):902-11. PubMed ID: 16156860
[TBL] [Abstract][Full Text] [Related]
7. Interaction between protein kinase C and actin in megakaryocyte polyploidization.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Anticancer Res; 1999; 19(5B):4193-8. PubMed ID: 10628374
[TBL] [Abstract][Full Text] [Related]
8. Sustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Bakić M; Ozawa K; Uemura N; Nishikawa M; Tojo A; Takahashi K; Tani K; Zaike Y; Ikebuchi K; Asano S
Leuk Res; 1993 Dec; 17(12):1079-82. PubMed ID: 7504152
[TBL] [Abstract][Full Text] [Related]
9. Protein content and number of nucleolar organizer regions are enhanced during phorbol ester-induced differentiation of cultured human megakaryocytic cells.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Anticancer Res; 1999; 19(4B):3229-35. PubMed ID: 10652616
[TBL] [Abstract][Full Text] [Related]
10. Expression of mRNA for serglycin core protein and other platelet alpha granule proteins is increased in human erythroleukemia cells by phorbol myristate acetate.
Schick BP; Thornton RD
Leukemia; 1993 Dec; 7(12):1955-9. PubMed ID: 7504770
[TBL] [Abstract][Full Text] [Related]
11. Modulation of MDM2/p53 and cyclin-activating kinase during the megakaryocyte differentiation of human erythroleukemia cells.
Datta NS; Long MW
Exp Hematol; 2002 Feb; 30(2):158-65. PubMed ID: 11823051
[TBL] [Abstract][Full Text] [Related]
12. Induction of the c-ski proto-oncogene by phorbol ester correlates with induction of megakaryocyte differentiation.
Namciu S; Lieberman MA; Stavnezer E
Oncogene; 1994 May; 9(5):1407-16. PubMed ID: 8152801
[TBL] [Abstract][Full Text] [Related]
13. Effect of phorbol myristate acetate on c-myc, beta-actin, and FV gene expression in morphologically recognizable human megakaryocytes: a kinetic analysis employing in situ hybridization.
Gewirtz AM; Shen YM
Exp Hematol; 1990 Sep; 18(8):945-52. PubMed ID: 2201557
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
[TBL] [Abstract][Full Text] [Related]
15. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
16. Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell line.
Catani L; Gugliotta L; Motta M; Tazzari P; Baravelli S; Tura S
Haematologica; 1998 May; 83(5):385-91. PubMed ID: 9658720
[TBL] [Abstract][Full Text] [Related]
17. Identification and conditions for selective expression of megakaryocytic markers in Friend erythroleukemia cells.
Paoletti F; Vannucchi AM; Mocali A; Caporale R; Burstein SA
Blood; 1995 Oct; 86(7):2624-31. PubMed ID: 7670106
[TBL] [Abstract][Full Text] [Related]
18. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages.
Murate T; Saga S; Hotta T; Asano H; Ito T; Kato K; Tsushita K; Kinoshita T; Ichikawa A; Yoshida S
Exp Cell Res; 1993 Sep; 208(1):35-43. PubMed ID: 8359227
[TBL] [Abstract][Full Text] [Related]
19. Role of phorbol diesters in in vitro murine megakaryocyte colony formation.
Long MW; Smolen JE; Szczepanski P; Boxer LA
J Clin Invest; 1984 Nov; 74(5):1686-92. PubMed ID: 6501566
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
